Octagon Therapeutics
octagontherapeutics.comLocations
Providence, RI, USA · Cambridge, MA, USA · Cambridge, MA, USA
industry
Biotechnology
Size
11-50 employees
Stage
Seed
founded in
2017
Octagon is developing new medicines for autoimmune and inflammatory diseases. The company is pioneering a selective immunomodulation approach based on glyco-immune checkpoint receptors that allows for precise targeting of disease-driving immune processes.
Something looks off?Open jobs at Octagon Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.